NEO-GLITIPNI: A Clinical Trial on Combined (Neo-)Adjuvant Intravenous Plus Intracranial Administration of Ipilimumab and Nivolumab in Recurrent Glioblastoma (clinicaltrials.gov) - Oct 3, 2026 - P1 | N=18 | Active, not recruiting | Sponsor: Universitair Ziekenhuis Brussel | Recruiting ➔ Active, not recruiting | Trial completion date: Dec 2025 ➔ Dec 2027 | Trial primary completion date: Jun 2025 ➔ Jun 2027
Enrollment closed • Trial completion date • Trial primary completion date • Brain Cancer • Glioblastoma • Oncology • Solid Tumor
|